Analyst Ratings for Prime Medicine (PRME)
PRME Rating Summary
PRME Price Target Summary
- Highest: $11.00 (Oppenheimer)
- Lowest: $4.25 (Citi)
- Average: $6.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.75 (+109%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
Avg. $ Target:
$6.75 (+109%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/6/2026 | Jones Trading | Boris Peaker | New Coverage | Buy (N/A) |
5.00 (N/A) |
3.32 (3.23) |
-2.71% | Details |
| 3/12/2026 | Oppenheimer | Kostas Biliouris | New Coverage | Outperform (N/A) |
11.00 (N/A) |
3.83 (3.23) |
-15.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
